Lenstatin debuts nutritional supplement for early cataracts

Lenstatin LLC announced in a press release the launch of a nutritional supplement specifically formulated to support healthy lens metabolism for patients with early cataract formation.

Lenstatin contains a proprietary antioxidant blend of micronutrients with anti-cataractogenic activity, including phycocyanin, alpha lipoic acid, glutathione, pyruvate, lutein/ zeaxanthin, astaxanthin, riboflavin, quercetin, silybum and curcumin, according to the company’s website.

Emerging science suggests that specific antioxidants have beneficial effects on the human lens metabolism as well as anti-cataractogenic activity, Lenstatin said. This supplement is formulated specifically to fulfill the role of targeted nutritional support in patients with early nonsurgical cataracts.

Scott W. Tunis, MD, FACS, said in the release that Lenstatin should not replace traditional preventive care and treatment for cataracts.

“However, in the setting of early cataracts, patients should also consider initiating lens health and anti-cataract nutritional support with Lenstatin,” he said.